Theratechnologies, Inc. (THTX)
3.39
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Theratechnologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2025 | -1.562 |
| February 28, 2025 | -2.058 |
| November 30, 2024 | -1.805 |
| August 31, 2024 | -2.939 |
| May 31, 2024 | -2.556 |
| February 29, 2024 | -2.404 |
| November 30, 2023 | -2.826 |
| August 31, 2023 | -1.396 |
| May 31, 2023 | -1.605 |
| February 28, 2023 | -2.042 |
| November 30, 2022 | -2.956 |
| August 31, 2022 | -3.678 |
| May 31, 2022 | -4.934 |
| February 28, 2022 | 5.621 |
| November 30, 2021 | 3.092 |
| August 31, 2021 | 2.285 |
| May 31, 2021 | 1.737 |
| February 28, 2021 | 1.498 |
| November 30, 2020 | 18.11 |
| August 31, 2020 | 6.996 |
| May 31, 2020 | 4.060 |
| February 29, 2020 | 2.995 |
| November 30, 2019 | 2.304 |
| August 31, 2019 | 1.752 |
| May 31, 2019 | 1.788 |
| Date | Value |
|---|---|
| February 28, 2019 | 1.641 |
| November 30, 2018 | 1.388 |
| August 31, 2018 | 1.368 |
| May 31, 2018 | 0.1178 |
| February 28, 2018 | 0.234 |
| November 30, 2017 | 0.2138 |
| August 31, 2017 | 0.1894 |
| May 31, 2017 | 0.2005 |
| February 28, 2017 | 0.3471 |
| November 30, 2016 | 0.5045 |
| August 31, 2016 | 0.4974 |
| May 31, 2016 | 0.5042 |
| February 29, 2016 | 0.8768 |
| November 30, 2015 | 0.8438 |
| August 31, 2015 | 0.9794 |
| May 31, 2015 | 2.269 |
| February 28, 2015 | 2.521 |
| November 30, 2014 | 2.18 |
| August 31, 2014 | 1.375 |
| May 31, 2014 | 0.9579 |
| February 28, 2014 | 0.00 |
| November 30, 2013 | 0.00 |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 0.0052 |
| Psyence Biomedical Ltd. | -- |
| Aurinia Pharmaceuticals, Inc. | 0.1043 |
| enGene Therapeutics, Inc. | 0.1445 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 51.27M |
| Total Liabilities (Quarterly) | 79.19M |
| Shareholders Equity (Quarterly) | -27.92M |